210 related articles for article (PubMed ID: 19157546)
1. Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children.
Goto H; Naruto T; Tanoshima R; Kato H; Yokosuka T; Yanagimachi M; Fujii H; Yokota S; Komine H
Leuk Res; 2009 Oct; 33(10):1386-91. PubMed ID: 19157546
[TBL] [Abstract][Full Text] [Related]
2. [Drug sensitivity of tumor cells in varieties of acute childhood leukemia].
Shman TV; Belevtsev MV; Buglova SE
Vopr Onkol; 2005; 51(5):558-62. PubMed ID: 16756010
[TBL] [Abstract][Full Text] [Related]
3. Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia.
Zhang LQ; Downie PA; Goodell WR; McCabe NR; LeBeau MM; Morgan R; Sklar J; Raimondi SC; Miley D; Goldberg A
Leukemia; 1993 Nov; 7(11):1865-74. PubMed ID: 8231254
[TBL] [Abstract][Full Text] [Related]
4. The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells.
Goto S; Goto H; Yokosuka T
Int J Hematol; 2016 May; 103(5):572-83. PubMed ID: 26886449
[TBL] [Abstract][Full Text] [Related]
5. Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines.
Beesley AH; Palmer ML; Ford J; Weller RE; Cummings AJ; Freitas JR; Firth MJ; Perera KU; de Klerk NH; Kees UR
Br J Cancer; 2006 Dec; 95(11):1537-44. PubMed ID: 17117183
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide increases in vitro sensitivity of childhood acute lymphoblastic leukemia cells to prednisolone and cytarabine.
Czyzewski K; Zaborowska A; Styczyński J
Arch Immunol Ther Exp (Warsz); 2006; 54(5):341-5. PubMed ID: 17031469
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
Kaspers GJ; Wijnands JJ; Hartmann R; Huismans L; Loonen AH; Stackelberg A; Henze G; Pieters R; Hählen K; Van Wering ER; Veerman AJ
Eur J Cancer; 2005 Jun; 41(9):1300-3. PubMed ID: 15869873
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
9. In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia.
Lönnerholm G; Thörn I; Sundström C; Frost BM; Abrahamsson J; Behrendtz M; Heldrup J; Jacobsson S; Li A; Olofsson T; Porwit A; Söderhäll S; Larsson R; Forestier E
Leuk Res; 2009 Jan; 33(1):46-53. PubMed ID: 18639340
[TBL] [Abstract][Full Text] [Related]
10. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
[TBL] [Abstract][Full Text] [Related]
11. Early detection of central nervous system relapse by polymerase chain reaction in children with B-precursor acute lymphoblastic leukemia.
de Haas V; Vet RJ; Verhagen OJ; Kroes W; van den Berg H; van der Schoot CE
Ann Hematol; 2002 Jan; 81(1):59-61. PubMed ID: 11807640
[No Abstract] [Full Text] [Related]
12. Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome.
Norén-Nyström U; Heyman M; Frisk P; Golovleva I; Sundström C; Porwit A; Roos G; Bergh A; Forestier E
Br J Haematol; 2009 Sep; 146(5):521-30. PubMed ID: 19594745
[TBL] [Abstract][Full Text] [Related]
13. [DNA index determined by flow cytometry in children with acute lymphoblastic leukemia as an additional diagnostic and prognostic element].
Sikorska-Fic B; Wasik M; Rokicka-Milewska R
Wiad Lek; 1998; 51 Suppl 4():103-6. PubMed ID: 10731951
[TBL] [Abstract][Full Text] [Related]
14. An uncommon case of childhood biphenotypic precursor-B/T acute lymphoblastic leukemia.
Costa ES; Thiago LS; Otazu IB; Ornellas MH; Land MG; Orfao A
Pediatr Blood Cancer; 2008 Apr; 50(4):941-2. PubMed ID: 17610263
[No Abstract] [Full Text] [Related]
15. Acute lymphoblastic leukemia.
Onciu M
Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
Styczynski J; Kurylak A; Wysocki M
Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
[TBL] [Abstract][Full Text] [Related]
17. Increased proportion of CD10-positive cells in a boy affected with common acute lymphoblastic leukemia in consolidation therapy.
Callea V; Sculli G; Comis M
Haematologica; 1997; 82(4):507. PubMed ID: 9299874
[No Abstract] [Full Text] [Related]
18. Methylated chrysin reduced cell proliferation, but antagonized cytotoxicity of other anticancer drugs in acute lymphoblastic leukemia.
Goto H; Yanagimachi M; Goto S; Takeuchi M; Kato H; Yokosuka T; Kajiwara R; Yokota S
Anticancer Drugs; 2012 Apr; 23(4):417-25. PubMed ID: 22205153
[TBL] [Abstract][Full Text] [Related]
19. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
[TBL] [Abstract][Full Text] [Related]
20. Leukaemia phenotype and ethnicity in children living in the United Arab Emirates.
Révész T; Pramathan T; Mpofu C
Haematologia (Budap); 1996; 28(1):9-12. PubMed ID: 9283898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]